External broker reports(aggregated public sources), Mirae Asset Securities

Mirae Asset Securities

External broker reports(aggregated public sources)

Leading full-service brokerage firm in Vietnam. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>For 2Q25, DIO Implant reported in-line revenue of W40.1bn (+158% YoY) and belowconsensus operating profit of W3bn (swinging to black YoY; OP margin of 7.5%).</li><li>Adjusted EBITDA came in at W9.7bn (adjusted EBITDA margin of 24.3%), also swinging to black YoY.</li><li>Domestic revenue was W6.4bn, while exports grew 93% YoY to W32.5bn. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

For 2Q25, DIO Implant reported in-line revenue of W40.1bn (+158% YoY) and belowconsensus operating profit of W3bn (swinging to black YoY; OP margin of 7.5%).Adjusted EBITDA came in at W9.7bn (adjusted EBITDA margin of 24.3%), also swinging to black YoY.Domestic revenue was W6.4bn, while exports grew 93% YoY to W32.5bn. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

DIO Implant (039840 KQ/Buy)Solid Underlying Performance Masked by Conservative Accounting Approach

South Korea

DIO Corp. manufactures dental implant and related device. The Company's product includes internal & external implant system, implant surgical device, dental material, and sterilizer. Dio also produces and installs public parking lot systems.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Dio Corp (039840 KS)

DIO Implant (039840 KQ/Buy)Solid Underlying Performance Masked by Conservative Accounting Approach

For 2Q25, DIO Implant reported in-line revenue of W40.1bn (+158% YoY) and belowconsensus operating profit of W3bn (swinging to black YoY; OP margin...

Mirae Asset Securities

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)